3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
18
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
7
Breast Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
5
Neoplasm Metastasis
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Head and Neck Neoplasms
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Squamous Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Pathologic Complete Response
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Melanoma
1
Locally Advanced Pancreatic Cancer
1
Gastric Adenocarcinoma
1
Gallbladder Neoplasms
1
Gallbladder Cancer Unresectable
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
Interventions
Cyclophosphamide
16
Rituximab
14
Magnetic Resonance Spectroscopy
8
obinutuzumab
7
fludarabine phosphate
7
fludarabine
7
Specimen Handling
7
Prednisone
7
Etoposide
6
Biopsy
6
tocilizumab
5
polatuzumab vedotin
5
ibrutinib
5
X-Rays
5
Whole-Body Irradiation
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Lenalidomide
5
Doxorubicin
5
venetoclax
4
Mycophenolic Acid
4
Cytarabine
4
Cyclosporine
4
Busulfan
4
pembrolizumab
3
glofitamab
3
acalabrutinib
3
Vincristine
3
Tacrolimus
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
130-nm albumin-bound paclitaxel
×
30 days
×
Clear all
No trials found.